Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT02987829 |
| Title | A Phase 1/2A Study of TRC253, an Androgen Receptor Antagonist, in Metastatic Castration-resistant Prostate Cancer Patients |
| Recruitment | Completed |
| Gender | male |
| Phase | Phase Ib/II |
| Variant Requirements | No |
| Sponsors | Tracon Pharmaceuticals Inc. |
| Indications | |
| Therapies | |
| Age Groups: | senior | adult |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| University of Alabama at Birmingham | Birmingham | Alabama | 35233 | United States | Details | |
| Honor Health | Scottsdale | Arizona | 85258 | United States | Details | |
| University of California at Los Angeles | Santa Monica | California | 90404 | United States | Details | |
| Memorial Sloan Kettering Cancer Center | New York | New York | 10065 | United States | Details | |
| University of Utah | Salt Lake City | Utah | 84112 | United States | Details |